Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.

BMC cancer - 26 May 2023

Kanai Ryo, Uehara Takeshi, Yoshizawa Takahiro, Kamakura Masato, Nakajima Tomoyuki, Kinugawa Yasuhiro, Iwaya Mai, Asaka Shiho, Kitazawa Masato, Nagaya Tadanobu, Ota Hiroyoshi

Abstract excerpt

BACKGROUND: ADP-ribosylation factor-like protein 4 C (ARL4C) is a member of the ARF small GTP-binding protein subfamily. The ARL4C gene is highly expressed in colorectal cancer (CRC). ARL4C protein promotes cell motility, invasion, and proliferation. METHODS: We investigated the characteristics of ARL4C by comparing its expression at the invasion front and relationships with clinicopathological data using...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ADP-Ribosylation Factors
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cell Movement

Share to Cell Proliferation

Share to Cell Transformation, Neoplastic

Share to Colorectal Neoplasms

Share to Epithelial-Mesenchymal Transition

Share to Gene Expression Regulation, Neoplastic

Source

Open in PubMed Open full text

Identifiers

PMID: 37237373
DOI: 10.1186/s12885-023-10958-4
PMCID: PMC10214640

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancer.PMID 37237373Read ↗

ARL4C is associated with epithelial-to-mesenchymal transition in colorectal cancerSemantic proximity Read ↗

Clinical relevance of ARF/ARL family genes and oncogenic function of ARL4C in endometrial cancerSemantic proximity Read ↗

ARL4C is A Key Driver of Gastric Cancer: An Integrative Analysis of ARL Family MembersSemantic proximity Read ↗

C 4.4 A is associated with tumor budding and epithelial–mesenchymal transition of colorectal cancerSemantic proximity Read ↗

RAS, Cellular Plasticity, and Tumor Budding in Colorectal CancerSemantic proximity Read ↗

Low miR200c expression in tumor budding of invasive front predicts worse survival in patients with localized colon cancer and is related to PD-L1 overexpressionSemantic proximity Read ↗

The Role of RAB GTPases and Its Potential in Predicting Immunotherapy Response and Prognosis in Colorectal CancerSemantic proximity Read ↗

Identification of ARL4C as a Peritoneal Dissemination-Associated Gene and Its Clinical Significance in Gastric CancerSemantic proximity Read ↗

LASP1 interacts with N-WASP to activate the Arp2/3 complex and facilitate colorectal cancer metastasis by increasing tumour budding and worsening the pattern of invasionSemantic proximity Read ↗

Epithelial-Mesenchymal Transition (EMT) Protein Expression in a Cohort of Stage II Colorectal Cancer Patients With Characterized Tumor Budding and Mismatch Repair Protein StatusSemantic proximity Read ↗

P4HA2 involved in SLUG-associated EMT predicts poor prognosis of patients with KRAS-positive colorectal cancer.Semantic proximity Read ↗

MicroRNA-200b is downregulated in colon cancer budding cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.